Concepedia
Statistics
Publications
21
Citations
1.6K
H-Index
18
Active since
1981
Affiliations
Eisai (United States)(Current)
Eli Lilly (United States)
Eisai (Japan)
Melvin J. Yu is an author at Eisai (United States) specializing in pharmacology, drug discovery, and medicine.
Publications per year
1981–2013
In vitro and in vivo anticancer activities of synthetic macrocyclic ketone analogues of halichondrin B.
Murray J. Towle, Kathleen A. Salvato, John Budrow et al. · PubMed · 2001 · 491 citations
Medicine, Medicinal Chemistry, Oncology +15
Induction of Morphological and Biochemical Apoptosis following Prolonged Mitotic Blockage by Halichondrin B Macrocyclic Ketone Analog E7389
Galina Kuznetsov, Murray J. Towle, Hongsheng Cheng et al. · Cancer Research · 2004 · 267 citations
Medicine, Oncology, Pharmacology +17
Eribulin Induces Irreversible Mitotic Blockade: Implications of Cell-Based Pharmacodynamics for <i>In vivo</i> Efficacy under Intermittent Dosing Conditions
Murray J. Towle, Kathleen A. Salvato, Bruce F. Wels et al. · Cancer Research · 2010 · 142 citations
Medicine, Oncology, Pharmacology +16
Novel Small Molecule Inhibitors of TLR7 and TLR9: Mechanism of Action and Efficacy In Vivo
Marc S. Lamphier, Wanjun Zheng, Eicke Latz et al. · Molecular Pharmacology · 2013 · 141 citations
Life Sciences, Immunology, Pharmacology +17
Structurally simplified macrolactone analogues of halichondrin B
Boris M. Seletsky, Yuan Wang, Lynn D. Hawkins et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 71 citations
Pharmacy, Chemistry, Medicinal Chemistry +12
1–5 of 21